文献速递前列腺癌膀胱癌与上尿路尿路上皮癌肾癌与肾肿瘤

评估COVID-19大流行期间非可延期大型泌尿肿瘤手术的负担以指导优先级策略:来自意大利三个高容量转诊中心的见解

Assessing the Burden of Nondeferrable Major Uro-oncologic Surgery to Guide Prioritisation Strategies During the COVID-19 Pandemic: Insights from Three Italian High-volume Referral Centres.
PubMed 文献 · Eur Urol · 2020-04-11

该研究基于意大利三个高容量学术中心的2387例大型泌尿肿瘤手术,评估高优先级手术的比例。结果显示32.3%被归类为高优先级,其中26.4%的高优先级手术患者ASA评分≥3。研究认为约三分之二的大型泌尿肿瘤择期手术在资源减少时可安全推迟或更改治疗方式。

要点

  • 32.3%的大型泌尿肿瘤手术为高优先级,其中根治性膀胱切除术占比最高(36.2%)。
  • 26.4%的高优先级手术患者ASA评分≥3,根治性膀胱切除术贡献最大(50%)。
  • 约三分之二的大型泌尿肿瘤择期手术在资源紧张时可安全推迟或更改治疗方式。

核心结论

  • 约三分之二的大型泌尿肿瘤择期手术在医疗资源减少时可安全推迟或更改治疗方式。
  • 高优先级手术中约四分之一患者围手术期风险较高,资源分配面临挑战。

研究设计与样本

  • 回顾性评估意大利三个高容量学术中心一年内的大型泌尿肿瘤手术量。
  • 共纳入2387例大型泌尿肿瘤手术,按优先级分类并分析患者围手术期风险。

主要发现

  • 2387例大型泌尿肿瘤手术中32.3%为高优先级。
  • 高优先级手术中根治性肾输尿管切除术占12.6%,肾切除术占17.3%,根治性前列腺切除术占33.9%,根治性膀胱切除术占36.2%。
  • 26.4%的高优先级手术患者ASA评分≥3,其中根治性膀胱切除术占该队列的50%。

关键数值与推荐

  • 高优先级定义基于专家小组针对低资源环境的建议。
  • 高围手术期风险定义为ASA评分≥3。

临床怎么用

  • 在COVID-19等资源紧张时期,可依据优先级分类推迟约三分之二的择期大型泌尿肿瘤手术。
  • 对高优先级且高围手术期风险患者(如ASA≥3的根治性膀胱切除术患者)需优先评估资源分配。

局限性

  • 数据来自意大利三个高容量学术中心,外推性可能受限。
  • 优先级分类基于专家建议,可能存在主观性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The coronavirus 2019 (COVID-19) pandemic has led to an unprecedented emergency scenario for all aspects of health care, including urology. At the time of writing, Italy was the country with the highest rates of both infection and mortality. A panel of experts recently released recommendations for prioritising urologic surgeries in a low-resource setting. Of note, major cancer surgery represents a compelling challenge. However, the burden of these procedures and the impact of such recommendations on urologic practice are currently unknown. To fill this gap, we assessed the yearly proportion of high-priority major uro-oncologic surgeries at three Italian high-volume academic centres. Of 2387 major cancer surgeries, 32.3% were classified as high priority (12.6% of radical nephroureterectomy, 17.3% of nephrectomy, 33.9% of radical prostatectomy, and 36.2% of radical cystectomy cases). Moreover, 26.4% of high-priority major cancer surgeries were performed in patients at higher perioperative risk (American Society of Anesthesiologists score ≥3), with radical cystectomy contributing the most to this cohort (50%). Our real-life data contextualise ongoing recommendations on prioritisation strategies during the current COVID-19 pandemic, highlighting the need for better patient selection for surgery. We found that approximately two-thirds of elective major uro-oncologic surgeries can be safely postponed or changed to another treatment modality when the availability of health care resources is reduced. PATIENT SUMMARY: We used data from three high-volume Italian academic urology centres to evaluate how many surgeries performed for prostate, bladder, kidney, and upper tract urothelial cancer can be postponed in times of emergency. We found that approximately two-thirds of patients with these cancers do not require high-priority surgery. Conversely, of patients requiring high-priority surgery, approximately one in four is considered at high perioperative risk. These patients may pose challenges in allocation of resources in critical scenarios such as the current COVID-19 pandemic.

来源:Eur Urol,查看原文。版权归原作者所有。

引用

  1. Campi R, Amparore D, Capitanio U, et al. Assessing the Burden of Nondeferrable Major Uro-oncologic Surgery to Guide Prioritisation Strategies During the COVID-19 Pandemic: Insights from Three Italian High-volume Referral Centres. Eur Urol. 2020. PMID: 32307215. doi:10.1016/j.eururo.2020.03.054

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。